Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
# SRPT # Sarepta Therapeutics $60-$80+ on FDA Approval.
Eteplirsen -first safest & effective Duchenne therapy ever!!!
# SRPT # Sarepta Therapeutics $60-$80+ on FDA Approval.
Eteplirsen -first safest & effective Duchenne therapy ever!!!
Mezaun Norman, no shame or ounce of dignity lmao. When an absolute SHAM this is and ever was
Sham
**ZFGN** Zafgen Inc soars on positive data!!!!! Bio winner today
ZFGN
**ZFGN** Zafgen Inc soars on positive data!!!!! Bio winner today
ZFGN
**ZFGN** Zafgen Inc soars on positive data!!!!!
ZFGN
**ZFGN** Zafgen Inc soars on positive data!!!!!
ZFGN
DISGRACE -Mezaun Norman, what an absolute joke, no shame dignity what so ever? How can people like this wake up and look at themselves in the mirror each day after what they've done lol. What a joke
FLXN - on the run-Flexion Therapeutic surging on positive PHASE 3 results- FDA ahead
$38-$42 targets- all held by insiders/affiliates
FLXN
FLXN - on the run-Flexion Therapeutic surging on positive PHASE 3 results- FDA ahead
$38-$42 targets- all held by insiders/affiliates
FLXN
FLXN - on the RUN!!! Flexion Therapeutic surging on positive PHASE 3 results- FDA ahead
$38-$42 targets- all held by insiders/affiliates
FLXN
FLXN - on the run-Flexion Therapeutic surging on positive PHASE 3 results- FDA ahead
$38-$42 targets- all held by insiders/affiliates
FLXN
FLXN - Flexion Therapeutic surging on positive results- FDA ahead
$38-$42 targets- all held by insiders/affiliates
FLXN
FLXN - Flexion Therapeutic surging on positive results- FDA ahead
$38-$42 targets- all held by insiders/affiliates
FLXN
**BLRX** BiolineRx strikes deal with MERCK
$5-$7++ ahead on this partnership coming to fruition
**BLRX** BiolineRx strikes deal with MERCK
$5-$7++ ahead on this partnership coming to fruition
**BLRX** BiolineRx Partners with MERCK
$5-$7 targets!! Drug combo for pancreatic cancer
BiolineRx to soar
**BLRX** BiolineRx Partners with MERCK
$5-$7 targets!! Drug combo for pancreatic cancer
BiolineRx to soar
**BLRX** BiolineRx Partners with MERCK
$5-$7 targets!!
**BLRX** BiolineRx Partners with MERCK
$5-$7 targets!!
***VLTC*** Carl Icahn + Voltari
Blast off
***VLTC*** Carl Icahn + Voltari
***VLTC*** Carl Icahn + Voltari
***VLTC*** Carl Icahn + Voltari
***VLTC*** Carl Icahn + Voltari
XBIT Short Squeeze PHASE III positive data out 2 million short shares
$25-35 targets ahead
XBiotech
XBIT Short Squeeze PHASE III positive data out 2 million short shares
$25-35 targets ahead
XBiotech
XBIT Short Squeeze PHASE III positive data out 2 million short shares
$25-35 targets ahead
XBiotech
XBIT Short Squeeze PHASE III positive data out 2 million short shares
$25-35 targets ahead
XBiotech
Xbiotech- XBIT, Phase III positive!!
$25-$35 targets ahead
Xbiotech- XBIT, Phase III positive!!
$25-$35 targets ahead
Xbiotech- XBIT, Phase III positive!!
$25-$35 targets ahead
Could see a 70-100%% ahead now
Xbiotech- XBIT, Phase III positive!!
$25-$35 targets ahead
Xbiotech- XBIT, Phase III positive!!
$25-$35 targets ahead
Xbiotech- XBIT, Phase III positive!!
$25-$35 targets ahead
VLTC- about to explode- Carl Icahn and Voltari, do we finally see the deal Coke to fruition
VLTC- about to explode- Carl Icahn and Voltari, do we finally see the deal Coke to fruition
***VLTC*** Voltari and Carl Icahn time!!!!
***VLTC*** Voltari and Carl Icahn time!!!!